Clinical Trial Update: A Study Assessing GW870086's Potential to Cause Skin Thinning [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated whether GW870086 could cause skin thinning in individuals with atopic dermatitis. The trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GW870086

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED